Results 251 to 260 of about 183,492 (354)

The association of serum uric acid level and the uric acid to creatinine ratio with non alcoholic fatty liver disease in children with obesity. [PDF]

Sci Rep
Arsoy HA, Kara Ö.
europepmc   +1 more source

The Effect of Bangpungtongsungsan on Insulin Resistance Induced by Non-alcoholic Fatty Liver Disease (NAFLD)

, 2018
Il-Bok Seo, Sang Hyun Ahn, Ki Bong Kim
openalex   +2 more sources

Author response for "Non‐Alcoholic Fatty Liver Disease in a sample of individuals with Bipolar Disorders: Results From the FACE‐BD Cohort"

, 2020
Ophélia Godin, Marion Leboyer, Raoul Belzeaux, Frank Bellivier, J. Loftus, Philippe Courtet, Caroline Dubertret, Sébastien Gard, Chantal Henry, Pierre‐Michel Llorca, Raymund Schwan, Christine Passerieux, Mircea Polosan, Ludovic Samalin, Émilie Olié, Bruno Étain, Bruno Étain, Caitlin Henry, E. Olié, Marion Leboyer, Émmanuel Haffen, PM Llorca, V. Barteau, S. Bensalem, Ophélia Godin, H. Laouamri, K. Souryis, Henri Mondor, S. Hotier, Agnès Pelletier, Noëmie Drancourt, J.P. Sanchez, E. Saliou, C. Hebbache, J. Petrucci, L. Willaume, E. Bourdin, Frank Bellivier, M. Carminati, Bruno Étain, Julia Maruani, Emeline Marlinge, Manon Meyrel, B. Antoniol, A. Desage, Sébastien Gard, A. Jutant, Katia M’Baïlara, I. Minois, L. Zanouy, Laurent Bardin, A. Cazals, P. Courtet, B. Deffinis, Déborah Ducasse, M. Gachet, Annabelle Henrion, Fanny Molière, B. Noisette, E. Olié, G. Tarquini, Raoul Belzeaux, N. Corréard, F. Groppi, Antoine Lefrère, Lauriane Lescalier, Éric Moreau, J. Pastol, M. Rebattu, B. Roux, N. Viglianese, Ricardo V. Cohen, Raymund Schwan, J.P. Kahn, Maria Milazzo, O. Wajsbrot‐Elgrabli, Thierry Bougerol, B. Fredembach, A. Suisse, Bahrije Halili, Arnaud Pouchon, Mircea Polosan, A.M. Galliot, I. Grévin, A.S. Cannavo, N. Kayser, C. Passerieux, Paul Roux, V. Aubin, I. Cussac, M.A Dupont, J. Loftus, I. Medecin, Caroline Dubertret, Norman A. Mazer, C. Portalier, C. Scognamiglio, A. Bing   +97 more
openalex   +1 more source

Absolute bioavailability and intravenous pharmacokinetics of N‐acetyl‐D‐mannosamine in humans

British Journal of Clinical Pharmacology, EarlyView.
Aims N‐acetyl‐D‐mannosamine monohydrate (ManNAc) is a naturally occurring monosaccharide that has attracted considerable attention for its potential in treating GNE myopathy, a rare autosomal recessive muscle disorder. Despite its promise as an oral treatment, the absolute bioavailability of oral ManNAc has not been determined and there has been no ...
Tahlia R. Meola, Guy Ludbrook, Gianfranco Fornasini, Olga Pavlova, Sumit Jain, Allan M. Evans, Stephanie E. Reuter   +6 more
wiley   +1 more source

Non-Alcoholic Fatty Liver Disease in Poultry: Risk Factors, Mechanism of Development, and Emerging Strategies. [PDF]

Int J Mol Sci
Imtiaz A, Bin Tahir MT, Zhao M, Gong D, Ge J, Geng T.   +5 more
europepmc   +1 more source

The Prevalence of Non-alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome and Obesity in Pediatric Population of North India

, 2013
Irshad Ahmad Parry
openalex   +1 more source

Faculty Opinions recommendation of Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease.

, 2020
Joel E. Lavine
openalex   +2 more sources

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

BMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo, Nan Li, Daiwei Zhang, Jingya Gu, Zhihuan Liao, Zihao Teng, Xiangfu Du, Peter S. Timashev, Shipeng Chen, Shuaidong Huo   +9 more
wiley   +1 more source

Mitophagy as a pivotal axis in non‑alcoholic fatty liver disease: From pathogenic mechanisms to therapeutic strategies (Review). [PDF]

Mol Med Rep
Huang Y, Xia X, Xu J, Wang Z, You Y, Du Q.   +5 more
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source